TH-263

CAS No. 313520-94-4

TH-263 ( —— )

Catalog No. M22572 CAS No. 313520-94-4

TH-263 is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257, and is a diaryl sulfonamide derivative.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 146 In Stock
10MG 228 In Stock
25MG 444 In Stock
50MG 620 In Stock
100MG 878 In Stock
500MG 1755 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TH-263
  • Note
    Research use only, not for human use.
  • Brief Description
    TH-263 is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257, and is a diaryl sulfonamide derivative.
  • Description
    TH-263 is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257, and is a diaryl sulfonamide derivative.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    313520-94-4
  • Formula Weight
    380.46
  • Molecular Formula
    C21H20N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NCc1ccccc1)c1ccc(cc1)S(=O)(=O)NCc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Manetti F. Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials. Eur J Med Chem. 2018 Jul 15;155:445-458.
molnova catalog
related products
  • Quercetin 3,5-O-digl...

    The seeds of Desurainia sophia.

  • Ganoderenic acid A

    Ganoderenic acid A has a potent hepatoprotective, and cytotoxic effects, it shows inhibitory activity on human aldose reductase in vitro.From the acidic fraction, potent human aldose reductase inhibitors, ganoderic acid C2 (1) and Ganoderenic acid A (2), were isolated together with three related compounds.

  • N-Benzyloxycarbonylg...

    N-benzyloxycarbonylglycine is a drug-lipid conjugates designed to promote brain penetration based on its lipophilicity and resemblance to lipids in biological membranes.